img

Global Ophthalmology Treatment Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Ophthalmology Treatment Market Research Report 2024

Drugs for ophthalmology, which are used to treat eye conditions and eye diseases such as glaucoma, conjunctivitis and others.
According to MRAResearch’s new survey, global Ophthalmology Treatment market is projected to reach US$ 53540 million in 2033, increasing from US$ 31240 million in 2022, with the CAGR of 8.0% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Ophthalmology Treatment market research.
The Ophthalmology Drugs market refers to the pharmaceuticals and medications used for the treatment of various eye conditions and diseases, including glaucoma, age-related macular degeneration, dry eye syndrome, and ocular infections. This market encompasses therapeutic areas such as ophthalmic solutions, ointments, and oral medications. The Ophthalmology Drugs market has been witnessing steady growth due to factors such as the increasing prevalence of eye disorders, the aging population, and technological advancements in the field of ophthalmology. Key players in the market include pharmaceutical companies, biotechnology firms, and generic drug manufacturers. Geographically, North America holds a significant market share, followed by Europe. However, the market in Asia Pacific is expected to witness substantial growth in the coming years, driven by the rising incidence of eye disorders and improving healthcare infrastructure.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Ophthalmology Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


AbbVie
Aerie Pharmaceuticals
Pfizer
Valeant
Bayer
Genentech
Novartis
Regeneron
Takeda
Santen Pharmaceutical
Segment by Type
Gels
Eye Solutions
Capsules & Tablets
Eye Drops
Ointments

Segment by Application


Hospital
Retail Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Ophthalmology Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ophthalmology Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Gels
1.2.3 Eye Solutions
1.2.4 Capsules & Tablets
1.2.5 Eye Drops
1.2.6 Ointments
1.3 Market by Application
1.3.1 Global Ophthalmology Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ophthalmology Treatment Market Perspective (2018-2033)
2.2 Ophthalmology Treatment Growth Trends by Region
2.2.1 Global Ophthalmology Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Ophthalmology Treatment Historic Market Size by Region (2018-2023)
2.2.3 Ophthalmology Treatment Forecasted Market Size by Region (2024-2033)
2.3 Ophthalmology Treatment Market Dynamics
2.3.1 Ophthalmology Treatment Industry Trends
2.3.2 Ophthalmology Treatment Market Drivers
2.3.3 Ophthalmology Treatment Market Challenges
2.3.4 Ophthalmology Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ophthalmology Treatment Players by Revenue
3.1.1 Global Top Ophthalmology Treatment Players by Revenue (2018-2023)
3.1.2 Global Ophthalmology Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Ophthalmology Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Ophthalmology Treatment Revenue
3.4 Global Ophthalmology Treatment Market Concentration Ratio
3.4.1 Global Ophthalmology Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ophthalmology Treatment Revenue in 2022
3.5 Ophthalmology Treatment Key Players Head office and Area Served
3.6 Key Players Ophthalmology Treatment Product Solution and Service
3.7 Date of Enter into Ophthalmology Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ophthalmology Treatment Breakdown Data by Type
4.1 Global Ophthalmology Treatment Historic Market Size by Type (2018-2023)
4.2 Global Ophthalmology Treatment Forecasted Market Size by Type (2024-2033)
5 Ophthalmology Treatment Breakdown Data by Application
5.1 Global Ophthalmology Treatment Historic Market Size by Application (2018-2023)
5.2 Global Ophthalmology Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Ophthalmology Treatment Market Size (2018-2033)
6.2 North America Ophthalmology Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Ophthalmology Treatment Market Size by Country (2018-2023)
6.4 North America Ophthalmology Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ophthalmology Treatment Market Size (2018-2033)
7.2 Europe Ophthalmology Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Ophthalmology Treatment Market Size by Country (2018-2023)
7.4 Europe Ophthalmology Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ophthalmology Treatment Market Size (2018-2033)
8.2 Asia-Pacific Ophthalmology Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Ophthalmology Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Ophthalmology Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Ophthalmology Treatment Market Size (2018-2033)
9.2 Latin America Ophthalmology Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Ophthalmology Treatment Market Size by Country (2018-2023)
9.4 Latin America Ophthalmology Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ophthalmology Treatment Market Size (2018-2033)
10.2 Middle East & Africa Ophthalmology Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Ophthalmology Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Ophthalmology Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Ophthalmology Treatment Introduction
11.1.4 AbbVie Revenue in Ophthalmology Treatment Business (2018-2023)
11.1.5 AbbVie Recent Development
11.2 Aerie Pharmaceuticals
11.2.1 Aerie Pharmaceuticals Company Detail
11.2.2 Aerie Pharmaceuticals Business Overview
11.2.3 Aerie Pharmaceuticals Ophthalmology Treatment Introduction
11.2.4 Aerie Pharmaceuticals Revenue in Ophthalmology Treatment Business (2018-2023)
11.2.5 Aerie Pharmaceuticals Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Ophthalmology Treatment Introduction
11.3.4 Pfizer Revenue in Ophthalmology Treatment Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 Valeant
11.4.1 Valeant Company Detail
11.4.2 Valeant Business Overview
11.4.3 Valeant Ophthalmology Treatment Introduction
11.4.4 Valeant Revenue in Ophthalmology Treatment Business (2018-2023)
11.4.5 Valeant Recent Development
11.5 Bayer
11.5.1 Bayer Company Detail
11.5.2 Bayer Business Overview
11.5.3 Bayer Ophthalmology Treatment Introduction
11.5.4 Bayer Revenue in Ophthalmology Treatment Business (2018-2023)
11.5.5 Bayer Recent Development
11.6 Genentech
11.6.1 Genentech Company Detail
11.6.2 Genentech Business Overview
11.6.3 Genentech Ophthalmology Treatment Introduction
11.6.4 Genentech Revenue in Ophthalmology Treatment Business (2018-2023)
11.6.5 Genentech Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Ophthalmology Treatment Introduction
11.7.4 Novartis Revenue in Ophthalmology Treatment Business (2018-2023)
11.7.5 Novartis Recent Development
11.8 Regeneron
11.8.1 Regeneron Company Detail
11.8.2 Regeneron Business Overview
11.8.3 Regeneron Ophthalmology Treatment Introduction
11.8.4 Regeneron Revenue in Ophthalmology Treatment Business (2018-2023)
11.8.5 Regeneron Recent Development
11.9 Takeda
11.9.1 Takeda Company Detail
11.9.2 Takeda Business Overview
11.9.3 Takeda Ophthalmology Treatment Introduction
11.9.4 Takeda Revenue in Ophthalmology Treatment Business (2018-2023)
11.9.5 Takeda Recent Development
11.10 Santen Pharmaceutical
11.10.1 Santen Pharmaceutical Company Detail
11.10.2 Santen Pharmaceutical Business Overview
11.10.3 Santen Pharmaceutical Ophthalmology Treatment Introduction
11.10.4 Santen Pharmaceutical Revenue in Ophthalmology Treatment Business (2018-2023)
11.10.5 Santen Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Ophthalmology Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Gels
Table 3. Key Players of Eye Solutions
Table 4. Key Players of Capsules & Tablets
Table 5. Key Players of Eye Drops
Table 6. Key Players of Ointments
Table 7. Global Ophthalmology Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Ophthalmology Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Ophthalmology Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Ophthalmology Treatment Market Share by Region (2018-2023)
Table 11. Global Ophthalmology Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Ophthalmology Treatment Market Share by Region (2024-2033)
Table 13. Ophthalmology Treatment Market Trends
Table 14. Ophthalmology Treatment Market Drivers
Table 15. Ophthalmology Treatment Market Challenges
Table 16. Ophthalmology Treatment Market Restraints
Table 17. Global Ophthalmology Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Ophthalmology Treatment Market Share by Players (2018-2023)
Table 19. Global Top Ophthalmology Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmology Treatment as of 2022)
Table 20. Ranking of Global Top Ophthalmology Treatment Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Ophthalmology Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Ophthalmology Treatment Product Solution and Service
Table 24. Date of Enter into Ophthalmology Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Ophthalmology Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Ophthalmology Treatment Revenue Market Share by Type (2018-2023)
Table 28. Global Ophthalmology Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Ophthalmology Treatment Revenue Market Share by Type (2024-2033)
Table 30. Global Ophthalmology Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Ophthalmology Treatment Revenue Market Share by Application (2018-2023)
Table 32. Global Ophthalmology Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Ophthalmology Treatment Revenue Market Share by Application (2024-2033)
Table 34. North America Ophthalmology Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Ophthalmology Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Ophthalmology Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Ophthalmology Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Ophthalmology Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Ophthalmology Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Ophthalmology Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Ophthalmology Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Ophthalmology Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Ophthalmology Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Ophthalmology Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Ophthalmology Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Ophthalmology Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Ophthalmology Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Ophthalmology Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 49. AbbVie Company Detail
Table 50. AbbVie Business Overview
Table 51. AbbVie Ophthalmology Treatment Product
Table 52. AbbVie Revenue in Ophthalmology Treatment Business (2018-2023) & (US$ Million)
Table 53. AbbVie Recent Development
Table 54. Aerie Pharmaceuticals Company Detail
Table 55. Aerie Pharmaceuticals Business Overview
Table 56. Aerie Pharmaceuticals Ophthalmology Treatment Product
Table 57. Aerie Pharmaceuticals Revenue in Ophthalmology Treatment Business (2018-2023) & (US$ Million)
Table 58. Aerie Pharmaceuticals Recent Development
Table 59. Pfizer Company Detail
Table 60. Pfizer Business Overview
Table 61. Pfizer Ophthalmology Treatment Product
Table 62. Pfizer Revenue in Ophthalmology Treatment Business (2018-2023) & (US$ Million)
Table 63. Pfizer Recent Development
Table 64. Valeant Company Detail
Table 65. Valeant Business Overview
Table 66. Valeant Ophthalmology Treatment Product
Table 67. Valeant Revenue in Ophthalmology Treatment Business (2018-2023) & (US$ Million)
Table 68. Valeant Recent Development
Table 69. Bayer Company Detail
Table 70. Bayer Business Overview
Table 71. Bayer Ophthalmology Treatment Product
Table 72. Bayer Revenue in Ophthalmology Treatment Business (2018-2023) & (US$ Million)
Table 73. Bayer Recent Development
Table 74. Genentech Company Detail
Table 75. Genentech Business Overview
Table 76. Genentech Ophthalmology Treatment Product
Table 77. Genentech Revenue in Ophthalmology Treatment Business (2018-2023) & (US$ Million)
Table 78. Genentech Recent Development
Table 79. Novartis Company Detail
Table 80. Novartis Business Overview
Table 81. Novartis Ophthalmology Treatment Product
Table 82. Novartis Revenue in Ophthalmology Treatment Business (2018-2023) & (US$ Million)
Table 83. Novartis Recent Development
Table 84. Regeneron Company Detail
Table 85. Regeneron Business Overview
Table 86. Regeneron Ophthalmology Treatment Product
Table 87. Regeneron Revenue in Ophthalmology Treatment Business (2018-2023) & (US$ Million)
Table 88. Regeneron Recent Development
Table 89. Takeda Company Detail
Table 90. Takeda Business Overview
Table 91. Takeda Ophthalmology Treatment Product
Table 92. Takeda Revenue in Ophthalmology Treatment Business (2018-2023) & (US$ Million)
Table 93. Takeda Recent Development
Table 94. Santen Pharmaceutical Company Detail
Table 95. Santen Pharmaceutical Business Overview
Table 96. Santen Pharmaceutical Ophthalmology Treatment Product
Table 97. Santen Pharmaceutical Revenue in Ophthalmology Treatment Business (2018-2023) & (US$ Million)
Table 98. Santen Pharmaceutical Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ophthalmology Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Ophthalmology Treatment Market Share by Type: 2022 VS 2033
Figure 3. Gels Features
Figure 4. Eye Solutions Features
Figure 5. Capsules & Tablets Features
Figure 6. Eye Drops Features
Figure 7. Ointments Features
Figure 8. Global Ophthalmology Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Ophthalmology Treatment Market Share by Application: 2022 VS 2033
Figure 10. Hospital Case Studies
Figure 11. Retail Pharmacy Case Studies
Figure 12. Ophthalmology Treatment Report Years Considered
Figure 13. Global Ophthalmology Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Ophthalmology Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Ophthalmology Treatment Market Share by Region: 2022 VS 2033
Figure 16. Global Ophthalmology Treatment Market Share by Players in 2022
Figure 17. Global Top Ophthalmology Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmology Treatment as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Ophthalmology Treatment Revenue in 2022
Figure 19. North America Ophthalmology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Ophthalmology Treatment Market Share by Country (2018-2033)
Figure 21. United States Ophthalmology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Ophthalmology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Ophthalmology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Ophthalmology Treatment Market Share by Country (2018-2033)
Figure 25. Germany Ophthalmology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Ophthalmology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Ophthalmology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Ophthalmology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Ophthalmology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Ophthalmology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Ophthalmology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Ophthalmology Treatment Market Share by Region (2018-2033)
Figure 33. China Ophthalmology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Ophthalmology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Ophthalmology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Ophthalmology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Ophthalmology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Ophthalmology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Ophthalmology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Ophthalmology Treatment Market Share by Country (2018-2033)
Figure 41. Mexico Ophthalmology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Ophthalmology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Ophthalmology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Ophthalmology Treatment Market Share by Country (2018-2033)
Figure 45. Turkey Ophthalmology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Ophthalmology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. AbbVie Revenue Growth Rate in Ophthalmology Treatment Business (2018-2023)
Figure 48. Aerie Pharmaceuticals Revenue Growth Rate in Ophthalmology Treatment Business (2018-2023)
Figure 49. Pfizer Revenue Growth Rate in Ophthalmology Treatment Business (2018-2023)
Figure 50. Valeant Revenue Growth Rate in Ophthalmology Treatment Business (2018-2023)
Figure 51. Bayer Revenue Growth Rate in Ophthalmology Treatment Business (2018-2023)
Figure 52. Genentech Revenue Growth Rate in Ophthalmology Treatment Business (2018-2023)
Figure 53. Novartis Revenue Growth Rate in Ophthalmology Treatment Business (2018-2023)
Figure 54. Regeneron Revenue Growth Rate in Ophthalmology Treatment Business (2018-2023)
Figure 55. Takeda Revenue Growth Rate in Ophthalmology Treatment Business (2018-2023)
Figure 56. Santen Pharmaceutical Revenue Growth Rate in Ophthalmology Treatment Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed